Using ultra-fast imaging to improve electron FLASH radiation therapy
Ultra-fast imaging for the safe delivery of electron FLASH radiation therapy
['FUNDING_SBIR_2'] · DOSEOPTICS, LLC · NIH-10708158
This study is looking at ways to make a new type of cancer treatment called electron FLASH radiation therapy safer and more effective by using super-fast imaging to keep an eye on the treatment as it happens, which could help patients get better results while protecting healthy tissue.
Quick facts
| Phase | ['FUNDING_SBIR_2'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | DOSEOPTICS, LLC (nih funded) |
| Locations | 1 site (LEBANON, UNITED STATES) |
| Trial ID | NIH-10708158 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing the safety and effectiveness of electron FLASH radiation therapy, a cutting-edge treatment that minimizes damage to healthy tissues while targeting tumors. By developing ultra-fast imaging techniques, the project aims to monitor radiation delivery in real-time, addressing the challenges posed by the rapid dose rates of FLASH therapy. The approach involves leveraging advanced detection methods to ensure precise treatment delivery, which could significantly improve patient outcomes. The research is being conducted in collaboration with Dartmouth-Hitchcock, a clinical site that has pioneered the use of FLASH therapy.
Who could benefit from this research
Good fit: Ideal candidates for this research are cancer patients who require radiation therapy as part of their treatment plan.
Not a fit: Patients who are not undergoing radiation therapy or those with conditions that do not involve tumors may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer radiation therapy options with reduced side effects for cancer patients.
How similar studies have performed: Previous research has shown promising results with FLASH therapy, indicating its potential for significant advancements in cancer treatment.
Where this research is happening
LEBANON, UNITED STATES
- DOSEOPTICS, LLC — LEBANON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: BRUZA, PETR — DOSEOPTICS, LLC
- Study coordinator: BRUZA, PETR
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.